Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 17 (RPL31P17) is a processed pseudogene found in the human genome, annotated with identifiers such as HGNC: 36995, NCBI Gene: 653773, and Ensembl: ENSG00000235225[5][8]. This pseudogene is related by sequence similarity to the functional RPL31 gene, which encodes a component of the large 60S ribosomal subunit involved in protein synthesis[2][3]. As a pseudogene, RPL31P17 does not encode a functional protein and, therefore, does not serve as a receptor, enzyme, transporter, or therapeutic target. There are no described biological functions, disease roles, drug interactions, mechanisms of action, known biomarker roles, or relevant safety concerns associated with this genomic entity. Its presence is typical of pseudogenes derived from genes encoding highly conserved ribosomal proteins[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 17 (RPL31P17).